Agency of medicines quits distribution of 22 medications in Moldova

19:37 | 10.08.2018 Category: Social

Chisinau, 10 August /MOLDPRES/ – The Medicines and Medical Devices Agency (AMDM) has quitted distributing 22 medications in Moldova, which contain active substance of Valsartan, made by a Chinese manufacturer.

The decision was taken in the context of a warning launched by the European Medicines Agency (EMA) following identification of carcinogenic potential impurity within active substance of Valsartan, manufactured by a Chinese manufacturer.

Thus, immediately after receiving the rapid alert, AMDM issued an order for the recall of all Valsartan – containing active medicines to the pharmacy level. As such, it was discontinued the distribution of 22 medicinal products with this active substance, manufactured by Chinese manufacturer, from wholesale to pharmacies and medical institutions, and their release from pharmacies.

According to AMDM's information and media communication service, a number of 28 other medicinal products containing active substance of Valsartan manufactured by other manufacturers are not registered in the State Nomenclature and are unaffected by the presence of impurity posing a high risk for health.

Currently, AMDM has received no info on the absence of Valsartan active medicines in community pharmacies.

The medicines with active substance of Valsartan are used to treat the cardiovascular disease.

(Reporter N. Sandu, editor L. Alcaza)

Any material published on the website of the Public Institution ’’A.I.S. Moldpres’’ (Moldpres News Agency) is intellectual peoperty of the Agency, protected by the copyright. The taking over or/and use of these materials will be made only with the Agency’s agreement and with compulsory reference to source.